Ana Marija Slišković, Jozefina Palić, Tamara Božina, Lana Ganoci, Majda Vrkić Kirhmajer, Vladimir Trkulja, Joško Bulum, Livija Šimičević
Original articles, Volume 34, June, Issue 2
KEYWORDS: adverse drug reactions; cardiovascular disease; hemorrhage; pharmacogenetics; risk factors; rivaroxaban
Ivana Ćelap, Sandra Margetić, Marija Brčić, Roman Mihić
Original Articles, Volume 30, February, Issue 1
KEYWORDS: chromogenic assay; dabigatran; rivaroxaban; apixaban; method comparison
Sandra Margetić, Ivana Ćelap, Diana Delić Brkljačić, Nikola Pavlović, Sandra Šupraha Goreta, Ivana Kobasić, Arijana Lovrenčić-Huzjan, Vanja Bašić Kes
Original Articles, Volume 30, February, Issue 1
KEYWORDS: apixaban; DOAC; factor Xa inhibitors; LMWH; rivaroxaban
Emmanuel J. Favaloro, Giuseppe Lippi
Review, Volume 22, October, Issue 3
KEYWORDS: haemostasis; coagulation; laboratory tests; anticoagulants; anti-thrombotics; Dabigatran; Rivaroxaban.
Copyright (©) 2010 - 2024 Croatian Society of Medical Biochemistry and Laboratory Medicine. Creative Commons License This work is licensed under a Creative Commons Attribution 4.0 International License
